Valuation: Repligen Corporation

Market Cap 7.84B 6.85B 6.29B 5.87B 11.12B 746B 11.31B 75.74B 29.35B 366B 29.44B 28.8B 1,261B P/E 2026 *
128x
P/E 2027 * 77.4x
Enterprise Value 7.59B 6.63B 6.09B 5.68B 10.76B 722B 10.94B 73.29B 28.4B 354B 28.48B 27.86B 1,221B EV / Sales 2026 *
9.27x
EV / Sales 2027 * 7.85x
Free-Float
94.26%
Yield 2026 *
-
Yield 2027 * -
1 day+1.85%
1 week-2.65%
Current month+3.62%
1 month+16.72%
3 months+20.04%
6 months-13.98%
Current year-13.72%
1 week 134.01
Extreme 134.01
147.58
1 month 117.59
Extreme 117.59
149.05
Current year 100.99
Extreme 100.99
175.77
1 year 100.99
Extreme 100.99
175.77
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 25.93
Extreme 25.93
327.32
Manager TitleAgeSince
Chief Executive Officer 56 2024-08-31
Director of Finance/CFO 52 2023-09-24
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Chairman 74 2011-12-13
Director/Board Member 60 2014-06-11
Director/Board Member 67 2015-09-30
Date Insider Type Main position Quantity % Market Cap.
06-24Sell

Chief Financial Officer

-733 0.0013%
05-13Free

Director

3,234 0.0057%
05-13Free

Director

3,234 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+1.90%-2.65%+11.36%-0.46% 7.84B
+2.95%+1.82%-29.21%-11.46% 161B
+4.26%+2.46%-6.55%-5.32% 101B
+2.01%+2.35%+0.86%+53.83% 56.12B
-1.22%-2.88%+53.69%+49.87% 53.35B
+2.60%+3.45%-11.66%-40.21% 42.13B
+2.70%+13.26% - - 35.29B
+3.58%+3.82%-14.73%-43.89% 26.57B
0.00%+5.46%+65.20%-3.40% 25.79B
+2.07%+2.92%-9.02%-1.09% 20.69B
Average +2.07%+3.59%+6.66%-0.24% 52.97B
Weighted average by Cap. +2.47%+2.09%-3.52%+0.66%

Financials

2026 *2027 *
Net sales 818M 715M 657M 612M 1.16B 77.9B 1.18B 7.9B 3.06B 38.21B 3.07B 3.01B 132B 943M 824M 757M 706M 1.34B 89.8B 1.36B 9.11B 3.53B 44.05B 3.54B 3.46B 152B
Net income 61.09M 53.38M 49.02M 45.71M 86.66M 5.82B 88.12M 590M 229M 2.85B 229M 224M 9.83B 101M 88.41M 81.18M 75.71M 144M 9.63B 146M 977M 379M 4.72B 380M 372M 16.28B
Net Debt -254M -222M -204M -190M -361M -24.22B -367M -2.46B -953M -11.88B -955M -935M -40.94B -432M -377M -347M -323M -613M -41.11B -623M -4.17B -1.62B -20.17B -1.62B -1.59B -69.49B
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
26-07-02 US$141.26 +1.63% 568,888
26-07-01 US$138.99 +1.87% 1,161,912
26-06-30 US$136.44 -0.41% 1,106,310
26-06-29 US$137.00 -6.81% 1,802,598
26-06-26 US$147.01 +1.23% 1,966,213
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
138.99USD
Average target price
176.11USD
Spread / Average Target
+26.70%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock